The aim of this study is to compare sublingual sufentanil and the administration device for its delivery (SSST-Zalviso) with the traditional strategies used for the control of postoperative pain to establish if there is an actual benefit for the patient and healthcare personnel.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
